Personalized circulating tumor DNA (ctDNA) analysis in predicting residual disease after neoadjuvant chemoradiotherapy (nCRT) for esophageal squamous cell carcinoma (ESCC)-MedSci.cn

Personalized circulating tumor DNA (ctDNA) analysis in predicting residual disease after neoadjuvant chemoradiotherapy (nCRT) for esophageal squamous cell carcinoma (ESCC)

Liu, ZC; Yang, Y; Liu, J; Zhang, H; Yu, H; Han, YC; Fu, XL; Zhang, H; Xiang, JX; Chen, SA; Li, X; Zhu, MJ; Li, ZG

JOURNAL OF CLINICAL ONCOLOGY, 2023; 41 (16):

科室
- - 订阅+
  - 更多科室
工具
服务